373 related articles for article (PubMed ID: 27821327)
21. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
23. Changing the time intervals between cisplatin cycles alter its ototoxic side effect.
Bielefeld EC; Gonzalez A; DeBacker JR
Hear Res; 2021 May; 404():108204. PubMed ID: 33618164
[TBL] [Abstract][Full Text] [Related]
24. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
25. miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells.
Ma W; Li J; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Chem Biol Interact; 2016 Feb; 245():72-81. PubMed ID: 26768586
[TBL] [Abstract][Full Text] [Related]
26. C-phycocyanin from
Kim YR; Do JM; Kim KH; Stoica AR; Jo SW; Kim UK; Yoon HS
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31010222
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
Fang B; Xiao H
Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
[TBL] [Abstract][Full Text] [Related]
28. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
29. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
[TBL] [Abstract][Full Text] [Related]
30. Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.
Rainey RN; Ng SY; Llamas J; van der Horst GT; Segil N
J Neurosci; 2016 Apr; 36(17):4758-70. PubMed ID: 27122034
[TBL] [Abstract][Full Text] [Related]
31. The intravenous administration of skin-derived mesenchymal stem cells ameliorates hearing loss and preserves cochlear hair cells in cisplatin-injected mice: SMSCs ameliorate hearing loss and preserve outer hair cells in mice.
Tsai SC; Lin FC; Chang KH; Li MC; Chou RH; Huang MY; Chen YC; Kao CY; Cheng CC; Lin HC; Hsu YC
Hear Res; 2022 Jan; 413():108254. PubMed ID: 34020824
[TBL] [Abstract][Full Text] [Related]
32. Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats.
Lee CH; Park SS; Lee DH; Lee SM; Kim MY; Choi BY; Kim SY
Neurosci Lett; 2020 Mar; 722():134838. PubMed ID: 32061715
[TBL] [Abstract][Full Text] [Related]
33. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.
Jie H; Tao S; Liu L; Xia L; Charko A; Yu Z; Bance M; Yin S; Robertson GS; Wang J
Gene Ther; 2015 Jul; 22(7):546-52. PubMed ID: 25809464
[TBL] [Abstract][Full Text] [Related]
34. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
[TBL] [Abstract][Full Text] [Related]
36. A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo.
Kashio A; Sakamoto T; Suzukawa K; Asoh S; Ohta S; Yamasoba T
J Neurosci Res; 2007 May; 85(7):1403-12. PubMed ID: 17387707
[TBL] [Abstract][Full Text] [Related]
37. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin ototoxicity involves cytokines and STAT6 signaling network.
Kim HJ; Oh GS; Lee JH; Lyu AR; Ji HM; Lee SH; Song J; Park SJ; You YO; Sul JD; Park C; Chung SY; Moon SK; Lim DJ; So HS; Park R
Cell Res; 2011 Jun; 21(6):944-56. PubMed ID: 21321603
[TBL] [Abstract][Full Text] [Related]
39. Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis.
Wu X; Li X; Song Y; Li H; Bai X; Liu W; Han Y; Xu L; Li J; Zhang D; Wang H; Fan Z
Neuropharmacology; 2017 Apr; 116():429-440. PubMed ID: 28062185
[TBL] [Abstract][Full Text] [Related]
40. Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction.
Kim SJ; Park C; Lee JN; Park R
Toxicol Appl Pharmacol; 2018 Aug; 353():43-54. PubMed ID: 29908243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
